Ginkgo Bioworks Holdings Total Assets 2020-2022 | DNA

Ginkgo Bioworks Holdings total assets from 2020 to 2022. Total assets can be defined as the sum of all assets on a company's balance sheet.
Ginkgo Bioworks Holdings Annual Total Assets
(Millions of US $)
2021 $2,071
2020 $675
2019 $0
Ginkgo Bioworks Holdings Quarterly Total Assets
(Millions of US $)
2022-09-30 $1,871
2022-06-30 $1,994
2022-03-31 $2,058
2021-12-31 $2,071
2021-09-30 $2,151
2021-06-30 $1,726
2021-03-31 $1,728
2020-12-31 $0
2020-09-30 $0
2019-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $3.395B $0.314B
Ginkgo Bioworks platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks, formerly known as Soaring Eagle Acquisition Corp., is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $155.188B 9.47
GSK (GSK) United Kingdom $72.345B 9.01
Bio-Rad Laboratories (BIO.B) United States $12.069B 28.64
QIAGEN (QGEN) Netherlands $11.333B 19.34
Myovant Sciences (MYOV) United Kingdom $2.604B 0.00
Arcus Biosciences (RCUS) United States $1.672B 25.10
Biohaven (BHVN) United States $1.264B 0.00
Emergent Biosolutions (EBS) United States $0.655B 5.15
ADC Therapeutics SA (ADCT) Switzerland $0.363B 0.00
Ambrx Biopharma (AMAM) United States $0.073B 0.00
Enzo Biochem (ENZ) United States $0.073B 0.00
Gelesis Holdings (GLS) United States $0.027B 0.00
SQZ Biotechnologies (SQZ) United States $0.025B 0.00